VILMA BENAVIDES: Open Payments
NPI 1215768759 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,988 in 58 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $231 · 2025 $1,988
Food & beverage: $1,988
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $387 |
| ABBVIE INC. | 22 | $312 |
| Lilly USA, LLC | 3 | $265 |
| AstraZeneca Pharmaceuticals LP | 7 | $248 |
| SI-BONE, INC. | 4 | $192 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| KYOWA KIRIN, INC. | 1 | $121 |
| Teva Pharmaceuticals USA, Inc. | 1 | $114 |
| CVRx, Inc. | 1 | $89 |
| Exact Sciences Corporation | 3 | $41 |
Products named: ZEPBOUND, Ozempic, QULIPTA, UBRELVY, Auvelity, CRYSVITA, AUSTEDO XR, Barostim Neo System.
Industry payments across TX — which companies pay providers there.
